Revascularization and outcomes in ischaemic left ventricular dysfunction after heart failure admission: The RevascHeart study

医学 射血分数 血运重建 心脏病学 危险系数 内科学 传统PCI 经皮冠状动脉介入治疗 心力衰竭 冠状动脉疾病 置信区间 心肌梗塞
作者
Carlos Moliner‐Abós,Maria Calvo‐Barceló,Eduard Solé‐González,Amandine Martin,Paula Fluvià‐Brugués,Jesús Sánchez‐Vega,Joan Vime‐Jubany,María Ferré Vallverdú,Manel Taurón Ferrer,Pablo Eduardo Tobías-Castillo,Juan Carlos de la Fuente Mancera,Pau Vilardell‐Rigau,Rosa Vila‐Olives,Carles Diez‐López,Antoni Bayés‐Genís,Dabit Arzamendi Aizpurua,Ignacio Ferreira‐González,Sònia Mirabet Pérez
出处
期刊:European Journal of Heart Failure [Elsevier BV]
标识
DOI:10.1002/ejhf.3463
摘要

Abstract Aims Despite numerous trials on revascularization in patients with heart failure (HF) and ischaemic left ventricular (LV) dysfunction, its role remains unsettled. Guideline‐directed medical therapy (GDMT) for HF has shown benefits on outcomes. This multicentre study aims to compare long‐term mortality between revascularization and GDMT in patients with ischaemic LV dysfunction following admission for HF. Methods and results Between 2012 and 2023, 408 patients admitted for HF with a LV ejection fraction (LVEF) of 40% or less and documented coronary artery disease (CAD) were included. Patients were categorized into two groups based on their initial treatment decision: revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass graft [CABG]) or GDMT. The primary outcome was rate of all‐cause or cardiovascular mortality, and secondary outcomes included type of revascularization (PCI vs. CABG) and LV reverse remodelling. After a median 44.6‐month follow‐up, 100 patients (33%) died in the revascularization group, compared to 44 (43%) in the GDMT group. Multivariate analysis showed no significant benefit of revascularization on all‐cause mortality (hazard ratio [HR] 0.81, 95% confidence interval [CI] 0.48–1.39, p = 0.45) or cardiovascular mortality (HR 0.97, 95% CI 0.62–1.52, p = 0.90) compared to GDMT. Neither CABG (HR 0.74, 95% CI 0.51–1.08, p = 0.13) nor PCI (HR 0.98, 95% CI 0.62–1.55, p = 0.93) demonstrated a mortality reduction compared to GDMT. Both groups experienced significant reductions in LV size and improvements in LVEF, greater in the revascularization group. Conclusion Revascularization did not outperform GDMT in ischaemic LV dysfunction following HF admission in this retrospective analysis. Larger prospective studies are needed to clarify the potential role of revascularization in improving outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
左眼天堂发布了新的文献求助10
2秒前
5秒前
WC241002292完成签到,获得积分10
5秒前
chi发布了新的文献求助10
5秒前
9秒前
香蕉觅云应助火星上冬亦采纳,获得10
10秒前
Learning发布了新的文献求助10
10秒前
12秒前
13秒前
科研通AI5应助Yuying采纳,获得10
13秒前
可积完成签到,获得积分10
14秒前
yuikiee发布了新的文献求助30
14秒前
FATYE发布了新的文献求助10
16秒前
andy发布了新的文献求助10
17秒前
Sigar完成签到 ,获得积分10
18秒前
科研通AI5应助Learning采纳,获得10
19秒前
dfb完成签到,获得积分10
19秒前
19秒前
梅梅发布了新的文献求助10
20秒前
21秒前
华仔应助科研通管家采纳,获得10
21秒前
星辰大海应助科研通管家采纳,获得10
21秒前
Singularity应助科研通管家采纳,获得10
21秒前
情怀应助科研通管家采纳,获得10
21秒前
田様应助科研通管家采纳,获得10
22秒前
tcf应助科研通管家采纳,获得10
22秒前
22秒前
斯文败类应助科研通管家采纳,获得10
22秒前
22秒前
钩子89应助科研通管家采纳,获得20
22秒前
在水一方应助科研通管家采纳,获得10
22秒前
李健应助科研通管家采纳,获得10
23秒前
科研通AI5应助科研通管家采纳,获得10
23秒前
23秒前
烟花应助科研通管家采纳,获得10
23秒前
Orange应助科研通管家采纳,获得20
23秒前
23秒前
我是老大应助科研通管家采纳,获得10
23秒前
领导范儿应助科研通管家采纳,获得10
23秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
CRC Handbook of Chemistry and Physics 104th edition 1000
Izeltabart tapatansine - AdisInsight 600
Introduction to Comparative Public Administration Administrative Systems and Reforms in Europe, Third Edition 3rd edition 500
Distinct Aggregation Behaviors and Rheological Responses of Two Terminally Functionalized Polyisoprenes with Different Quadruple Hydrogen Bonding Motifs 450
THE STRUCTURES OF 'SHR' AND 'YOU' IN MANDARIN CHINESE 320
中国化工新材料产业发展报告(2024年) 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3761965
求助须知:如何正确求助?哪些是违规求助? 3305655
关于积分的说明 10135129
捐赠科研通 3019805
什么是DOI,文献DOI怎么找? 1658407
邀请新用户注册赠送积分活动 792030
科研通“疑难数据库(出版商)”最低求助积分说明 754783